| Company Name: |
Sichuan Wei Keqi Biological Technology Co., Ltd.
|
| Tel: |
028-81700200 18116577057 |
| Email: |
3003855609@qq.com |
| Products Intro: |
Product Name:23-epi-26-Deoxyactein
CAS:501938-01-8
Purity:HPLC>=90% Package:5mg;10mg;20mg;50mg;100mg;200mg;500mg;1g
|
| Company Name: |
Nanning Saifir Biotechnology Co., Ltd.
|
| Tel: |
18877121284 |
| Email: |
1309367106@qq.com |
| Products Intro: |
Product Name:23-epi-26-deoxyactein
CAS:501938-01-8
Purity:95.0%;98.0% HPLC Package:5mg;10mg;100mg
|
| Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
customer_service@efebio.com |
| Products Intro: |
Product Name:23-epi-26-Deoxyactein
CAS:501938-01-8
Purity:95.00% Package:5mg;10mg;50mg
|
|
| | DEOXYACTEIN, 27-(23-EPI-26-DEOXYACTEIN)(RG) Basic information |
| Product Name: | DEOXYACTEIN, 27-(23-EPI-26-DEOXYACTEIN)(RG) | | Synonyms: | DEOXYACTEIN, 27-(23-EPI-26-DEOXYACTEIN)(RG);β-D-Xylopyranoside, (3β,12β,16β,23R,24R,25R)-12-(acetyloxy)-16,23:23,26:24,25-triepoxy-9,19-cyclolanostan-3-yl;23-epi-26-Deoxyactein-RM;Deoxyactein;23-epi-26-Deoxyactein | | CAS: | 501938-01-8 | | MF: | C37H56O10 | | MW: | 660.85 | | EINECS: | | | Product Categories: | | | Mol File: | 501938-01-8.mol |  |
| | DEOXYACTEIN, 27-(23-EPI-26-DEOXYACTEIN)(RG) Chemical Properties |
| density | 1.32±0.1 g/cm3(Predicted) | | storage temp. | 2-8°C | | pka | 13.03±0.70(Predicted) | | form | Solid | | color | White to off-white |
| | DEOXYACTEIN, 27-(23-EPI-26-DEOXYACTEIN)(RG) Usage And Synthesis |
| Uses | pharmaceutical | | Definition | ChEBI: 23-epi-26-deoxyactein is a triterpenoid. It has a role as a metabolite. | | in vivo | 23-epi-26-Deoxyactein (DA: 5 and 10 mg/kg/d) significantly lowers body weight gain, fat mass, and liver weight in HFD-fed mice. 23-epi-26-Deoxyactein (DA) also reduces insulin resistance and serum lipoprotein levels in HFD-fed mice[1].
23-epi-26-Deoxyactein (DA) promotes adipocyte lipolysis in mice through activating the AMPK signaling and SIRT1-FOXO1 pathway[1].
| Animal Model: | Diet induced obesity in C57BL/6 mice[1]. | | Dosage: | 1-10 mg/kg. | | Administration: | Orally, daily for 12 weeks. | | Result: | Lowered body weight gain, fat mass, and liver weight.
5 mg/kg/d DA significantly improved HFD-induced glucose intolerance.
|
|
| | DEOXYACTEIN, 27-(23-EPI-26-DEOXYACTEIN)(RG) Preparation Products And Raw materials |
|